Illumina Stock Takes a Hit on Adverse Jury Decision | GenomeWeb
Shares in Illumina closed down 7.5 percent for the week ended Tuesday, due mostly to a jury’s finding earlier this week that the firm had infringed five Affymetrix patents (see related article). The company led all decliners in a down week for the BCW Index and US stocks, in general, which dropped sharply on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."